Uniting oncology leaders to advance genomic access
The Illumina GOAL Summit is turning advocacy into action
The Illumina GOAL Summit is turning advocacy into action
With groundbreaking constellation and 5-base technology, Illumina is ushering in a new era of multiomics
How our Bengaluru offices are celebrating, reflecting, and getting ready for new beginnings
At ESMO 2025, Illumina teams up with Pillar Biosciences to showcase their powerful combination of NGS tests
Illumina Protein Prep is giving University of Colorado researchers a powerful, unbiased tool to interrogate these unique conditions
| Date | Publication | Title |
|---|---|---|
| 23 Jun 2025 | Endpoints News | Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics |
| 17 Jun 2025 | Forbes | Illumina’s New CIO Brings R&D Mindset As AI Transforms Genomics |
| 13 Jun 2025 | GEN | Silver Anniversary of the Human Genome Project |
| 13 Jun 2025 | GEN | Proteomics Partnerships Move Multiomics from Theory to Practice |
| 12 Jun 2025 | Colorado State University | The pathogen hunter: Next-Generation Sequencing tracks down genetic mutations |

At Illumina, we push boundaries. We think beyond the conventional. We dream big. With the energy of so many bright and accomplished people, the opportunities are endless.
Search for JobsIf you are a member of the media:
If you are not a member of the media, please visit Contact Us.